ストックスクリーナーアプリを入手
5.4607
4.86%
-0.1093
前日終値:
$5.57
開ける：
$5.59
24時間の取引高:
33,538
Relative Volume:
0.01
時価総額：
$77.67M
収益：
$37.79M
当期純損益:
$-10.38M
株価収益率:
-7.4804
EPS:
-0.73
ネットキャッシュフロー:
$-1.00M
1週間 パフォーマンス:
-19.83%
1か月 パフォーマンス:
+14.20%
6か月 パフォーマンス:
+310.78%
1年 パフォーマンス:
+192.77%
1日の値動き範囲:
$5.19
$5.59
1週間の範囲:
$4.64
$6.70
52週間の値動き範囲:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
名前
Cumberland Pharmaceuticals Inc
セクター
電話
615-255-0068
住所
2525 WEST END AVENUE, NASHVILLE,, TN
CPIX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
5.41 | 77.67M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
160.02 | 72.14B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.04 | 47.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.19 | 45.76B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.67B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.30 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2012-11-12 | 繰り返されました | UBS | Neutral |
| 2011-02-01 | 繰り返されました | UBS | Neutral |
| 2010-12-16 | ダウングレード | UBS | Buy → Neutral |
| 2010-08-17 | ダウングレード | Jefferies | Buy → Hold |
| 2010-08-17 | 繰り返されました | Morgan Joseph | Buy |
| 2010-08-17 | 繰り返されました | UBS | Buy |
| 2010-05-14 | 繰り返されました | Morgan Joseph | Buy |
すべてを表示
Cumberland Pharmaceuticals Inc (CPIX) 最新ニュース
Burn Pain Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Cumberland Pharma, Janssen R&D, Cephalon - The Globe and Mail
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Earnings call transcript: Cumberland Q4 2024 results show revenue rise By Investing.com - Investing.com Australia
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Rating Upgraded by StockNews.com - Defense World
Cumberland Pharmaceuticals Inc. (CPIX) reports earnings - Quartz
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2024 Earnings Call Transcript - MSN
Cumberland Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire
Cumberland Pharma stock soars to 52-week high of $7.25 By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals: Key Insights from Earnings Call - TipRanks
Cumberland Pharma stock soars to 52-week high of $7.25 - Investing.com India
Cumberland Pharmaceuticals Inc (CPIX) Q4 2024 Earnings Call Highlights: Revenue Growth and ... By GuruFocus - Investing.com Canada
Cumberland: Q4 Earnings Snapshot - Midland Daily News
Cumberland Pharmaceuticals Reports Revenue Growth and Strategic Advances - TipRanks
Earnings call transcript: Cumberland Q4 2024 results show revenue rise - Investing.com
Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth - TradingView
Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth -March 04, 2025 at 04:52 pm EST - Marketscreener.com
Cumberland: Q4 Earnings Snapshot -March 04, 2025 at 04:51 pm EST - Marketscreener.com
Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials - BioSpace
Glenmark Pharmaceuticals Acquires & Launches Acetylcysteine Injection In The U.S. - BW Healthcare World
Glenmark acquires Acetylcysteine injection, launches in US market - BusinessLine
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Held Back By Insufficient Growth Even After Shares Climb 117% - Simply Wall St
Investor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire
Cumberland Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS - Quantisnow
When Will Cumberland Pharmaceuticals Reveal Its 2024 Performance? Key Date for Specialty Pharma Investors - StockTitan
(CPIX) Trading Report - Stock Traders Daily
Does Cumberland Pharmaceuticals (NASDAQ:CPIX) Have A Healthy Balance Sheet? - Simply Wall St
Cumberland Pharma stock soars to 52-week high of $6.43 By Investing.com - Investing.com South Africa
Cumberland Pharma stock soars to 52-week high of $6.43 - Investing.com
Cumberland Pharmaceuticals' Pneumonia Injection Receives Approval in China -February 18, 2025 at 08:19 am EST - Marketscreener.com
VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA - Finansavisen
Corneal Ulcer Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, NDA Approval, Prevalence, Incidence, Therapies, and Companies by DelveInsight - The Globe and Mail
Short Interest in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Decreases By 56.3% - MarketBeat
Cumberland Pharmaceuticals Inc. Receives Notification from the U.S. Food and Drug Administration - Marketscreener.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated at StockNews.com - MarketBeat
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Cumberland Pharmaceuticals ups common stock offering - MSN
Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by StockNews.com - Defense World
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
An Analysis of Cumberland Pharmaceuticals Inc (CPIX)’s Potential Price Growth - Knox Daily
Future Outlook And Stock Price Performance For Cumberland Pharmaceuticals Inc (NASDAQ: CPIX) - Marketing Sentinel
Cumberland Pharmaceuticals Inc (CPIX) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Cumberland Pharmaceuticals Inc (CPIX) Shares Down Despite Recent Market Volatility - The News Heater
Cumberland Pharmaceuticals Inc (CPIX) 財務データ
収益
当期純利益
現金流量
EPS
1.73%
0.82%
大文字化:
|
ボリューム (24 時間):